TYRO3 promotes tumorigenesis and drug resistance in colorectal cancer by enhancing the epithelial-mesenchymal transition process

Colorectal cancer (CRC) is a leading cause of cancer mortality worldwide. Although considerable advances in CRC treatment have been achieved, effective treatment improvement has hit a bottleneck. This study demonstrated that TYRO3 expression was aberrantly increased in CRC tissues with prognosis ass...

Descripción completa

Detalles Bibliográficos
Autores principales: Shao, Xinyu, Sun, Yibin, Zhong, Kaiqiang, Gu, Jinrong, Yu, Yang, Hu, Tong, Kuai, Xiaoyi, Xing, Yechen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188355/
https://www.ncbi.nlm.nih.gov/pubmed/37116196
http://dx.doi.org/10.18632/aging.204656

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188355/
https://www.ncbi.nlm.nih.gov/pubmed/37116196
http://dx.doi.org/10.18632/aging.204656

Ejemplares similares